BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36892949)

  • 1. Early mortality in acute myeloid leukemia with KMT2A rearrangement is associated with high risk of bleeding and disseminated intravascular coagulation.
    Nguyen D; Kantarjian HM; Short NJ; Qiao W; Ning J; Cuglievan B; Daver NG; DiNardo CD; Jabbour EJ; Kadia TM; Borthakur G; Garcia-Manero G; Konopleva MY; Andreeff M; Ravandi-Kashani F; Sasaki K; Issa GC
    Cancer; 2023 Jun; 129(12):1856-1865. PubMed ID: 36892949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of outcomes in adults with acute myeloid leukemia and KMT2A rearrangements.
    Issa GC; Zarka J; Sasaki K; Qiao W; Pak D; Ning J; Short NJ; Haddad F; Tang Z; Patel KP; Cuglievan B; Daver N; DiNardo CD; Jabbour E; Kadia T; Borthakur G; Garcia-Manero G; Konopleva M; Andreeff M; Kantarjian HM; Ravandi F
    Blood Cancer J; 2021 Sep; 11(9):162. PubMed ID: 34588432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic and molecular genetic characterization of KMT2A-PTD positive acute myeloid leukemia in comparison to KMT2A-Rearranged acute myeloid leukemia.
    Vetro C; Haferlach T; Meggendorfer M; Stengel A; Jeromin S; Kern W; Haferlach C
    Cancer Genet; 2020 Jan; 240():15-22. PubMed ID: 31698332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive immunophenotypic study of acute myeloid leukemia with KMT2A (MLL) rearrangement in adults: A single-institution experience.
    Konoplev S; Wang X; Tang G; Li S; Wang W; Xu J; Pierce SA; Jia F; Jorgensen JL; Ravandi F; Issa GC; Medeiros LJ; Wang SA
    Cytometry B Clin Cytom; 2022 Mar; 102(2):123-133. PubMed ID: 34964255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KMT2A-rearranged infantile acute myeloid leukemia masquerading as juvenile myelomonocytic leukemia.
    Kanayama T; Imamura T; Kawabe Y; Osone S; Tahara J; Iwasaki F; Miyagawa N; Goto H; Imashuku S; Hosoi H
    Int J Hematol; 2018 Dec; 108(6):665-669. PubMed ID: 30143999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trying to outRun-DIC in KMT2Ar AML: It's tricky.
    Venugopal S; Taylor J
    Cancer; 2023 Jun; 129(12):1797-1799. PubMed ID: 36892942
    [No Abstract]   [Full Text] [Related]  

  • 7. Hematopoietic stem cell transplantation for pediatric acute myeloid leukemia patients with KMT2A rearrangement; A nationwide retrospective analysis in Japan.
    Miyamura T; Kudo K; Tabuchi K; Ishida H; Tomizawa D; Adachi S; Goto H; Yoshida N; Inoue M; Koh K; Sasahara Y; Fujita N; Kakuda H; Noguchi M; Hiwatari M; Hashii Y; Kato K; Atsuta Y; Okamoto Y
    Leuk Res; 2019 Dec; 87():106263. PubMed ID: 31707119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KMT2A rearranged acute lymphoblastic leukaemia: Unravelling the genomic complexity and heterogeneity of this high-risk disease.
    Forgione MO; McClure BJ; Eadie LN; Yeung DT; White DL
    Cancer Lett; 2020 Jan; 469():410-418. PubMed ID: 31705930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric
    Pollard JA; Guest E; Alonzo TA; Gerbing RB; Loken MR; Brodersen LE; Kolb EA; Aplenc R; Meshinchi S; Raimondi SC; Hirsch B; Gamis AS
    J Clin Oncol; 2021 Oct; 39(28):3149-3160. PubMed ID: 34048275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ISTH DIC-score predicts early mortality in patients with non-promyelocitic acute myeloid leukemia.
    Paterno G; Palmieri R; Tesei C; Nunzi A; Ranucci G; Mallegni F; Moretti F; Meddi E; Tiravanti I; Marinoni M; Page C; Fagiolo S; Buzzatti E; Secchi R; Gurnari C; Maurillo L; Buccisano F; Venditti A; Del Principe MI
    Thromb Res; 2024 Apr; 236():30-36. PubMed ID: 38387301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coagulopathy in cytogenetically and molecularly distinct acute leukemias at diagnosis: Comprehensive study.
    Guo Z; Chen X; Tan Y; Xu Z; Xu L
    Blood Cells Mol Dis; 2020 Mar; 81():102393. PubMed ID: 31918382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repressing HIF-1α-induced HDAC9 contributes to the synergistic effect of venetoclax and MENIN inhibitor in KMT2Ar AML.
    Ling Q; Zhou Y; Qian Y; Qian J; Zhang Y; Wang J; Zhu Y; Zhou Y; Wei J; Yang C; Sun J; Yu W; Jin J; Zhang X
    Biomark Res; 2023 Dec; 11(1):105. PubMed ID: 38053201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MLL gene amplification in acute myeloid leukemia and myelodysplastic syndromes is associated with characteristic clinicopathological findings and TP53 gene mutation.
    Tang G; DiNardo C; Zhang L; Ravandi F; Khoury JD; Huh YO; Muzzafar T; Medeiros LJ; Wang SA; Bueso-Ramos CE
    Hum Pathol; 2015 Jan; 46(1):65-73. PubMed ID: 25387813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor treatment responses were related to poor outcomes in pediatric B cell acute lymphoblastic leukemia with KMT2A rearrangements.
    Wen J; Zhou M; Shen Y; Long Y; Guo Y; Song L; Xiao J
    BMC Cancer; 2022 Aug; 22(1):859. PubMed ID: 35933338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute promyelocytic leukemia is a distinct subset of acute myelocytic leukemia with unique clinicopathologic characteristics including longer duration of relapse free survival: experience in 13 cases.
    Lee KH; Kim DH; Lee JS; Suh CW; Kim SW; Kim SB; Lee JH; Doh BS; Chi HS; Lee MS
    J Korean Med Sci; 1994 Dec; 9(6):437-43. PubMed ID: 7786438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetics and associated mutation profile in patients with acute monocytic leukemia.
    Xing S; Wang B; Gao Y; Li M; Wang T; Sun Y; Shen Y; Chao H
    Int J Lab Hematol; 2019 Aug; 41(4):485-492. PubMed ID: 31099482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational landscape and clinical outcome of pediatric acute myeloid leukemia with 11q23/KMT2A rearrangements.
    Yuen KY; Liu Y; Zhou YZ; Wang Y; Zhou DH; Fang JP; Xu LH
    Cancer Med; 2023 Jan; 12(2):1418-1430. PubMed ID: 35833755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: a retrospective study.
    Baysal M; Gürsoy V; Hunutlu FC; Erkan B; Demirci U; Bas V; Gulsaran SK; Pinar IE; Ersal T; Kirkizlar TA; Atli EI; Kirkizlar HO; Ümit EG; Gürkan H; Ozkocaman V; Ozkalemkas F; Demir AM; Ali R
    Ann Hematol; 2022 May; 101(5):1049-1057. PubMed ID: 35190843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of Disseminated Intravascular Coagulation in Acute Leukemias.
    Ten Cate H; Leader A
    Hamostaseologie; 2021 Apr; 41(2):120-126. PubMed ID: 33860520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disseminated Intravascular Coagulation in Acute Promyelocytic Leukemia Patients: A Retrospective Analysis of Outcomes and Healthcare Burden in US Hospitals.
    Patel R; Patel D; Patel M; Ohemeng-Dapaah J; Onyechi A; Patel Z; Yang C; Shaikh S
    Turk J Haematol; 2024 Mar; 41(1):1-8. PubMed ID: 38374587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.